Key Insights

Highlights

Treatment Research

2 treatments under study, led by Mesenchymal Stem Cell Conditioned Mediumderived Pleiotropic Factor

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04235296Phase 1UnknownPrimary

Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound

Showing all 1 trials

Research Network

Common Treatments

  • Mesenchymal Stem Cell Conditioned Mediumderived Pleiotropic Factor1
  • Epidermal Growth Factor1

Active Sponsors

  • Chinese PLA General Hospital1

Top Investigators

Activity Timeline